Programming: Maximizing Benefit and Minimizing Morbidity Programming

Paul A. Friedman, Charles D. Swerdlow, Samuel J. Asirvatham, David L. Hayes, Avi Sabbag

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review


Modern implantable cardioverter-defibrillators (ICDs) include many of the features seen in pacemakers and are therefore capable of adequately treating bradycardiaAs the utilization of ICDs expanded and the majority of devices are now implanted for the primary prevention of sudden arrhythmic death, we are faced with the challenge of tailoring and empiric programming of devices in an increasingly heterogeneous populationCurrently, the only available subcutaneous ICD is the device from Boston ScientificThis system was designed to be very simple for management and programingThe effectiveness of resynchronization is also modified by the programmed atrioventricular delay and the offset between right ventricular and left ventricular timingCardiac resynchroniztion therapy devices incorporate algorithms designed to overcome these events in order to promote continuous resynchronizationWith a thorough understanding of device operation function, it can indeed be optimized to provide life-prolonging therapy with minimal morbidity.

Original languageEnglish
Title of host publicationCardiac Pacing, Defibrillation and Resynchronization
Subtitle of host publicationA Clinical Approach, Fourth Edition
Number of pages54
ISBN (Electronic)9781119264002
ISBN (Print)9781119263968
StatePublished - 1 Jan 2021
Externally publishedYes


Dive into the research topics of 'Programming: Maximizing Benefit and Minimizing Morbidity Programming'. Together they form a unique fingerprint.

Cite this